EHA 2026 Update
Virtual Event
We invite you to join us to discuss selected acute leukemia abstracts from EHA 2026
7 events found.
Events
-
-
-
-
The Evolving Treatment Landscape of Adult Ph+ve ALL: The CLSG-ALL-2 Study
Virtual EventWe invite you to join a discussion about the upcoming CLSG-ALL-2 Trial.
-
-
Management of FLT3-Mutated AML: What’s New in 2026?
Virtual EventWe invite you to join a discussion about the management of FLT3-mutated AML and what’s new in 2026. The discussion will cover the impact of newly available Quizartinib on Canadian practice, and recent advances in FLT3-ITD MRD testing.
-
-
Controversies in the Management of AML in the Elderly 2025: An FAQ-Based Discussion
Series of webinars to discuss Acute Leukemia management dilemmas. The first one will be a discussion of ongoing questions in the administration of AML in the Elderly.
-
-
CLSG/GCEL Launch Webinar 3
The founding goals of CLSG are to advance the diagnosis and treatment of leukemia in Canada, by identifying diagnostic and management best practices, promoting Canada-wide standards-of-care, fostering clinical and basic leukemia research, and improving new drug access.
-
CLSG/GCEL Launch Webinar 2
The founding goals of CLSG are to advance the diagnosis and treatment of leukemia in Canada, by identifying diagnostic and management best practices, promoting Canada-wide standards-of-care, fostering clinical and basic leukemia research, and improving new drug access.
-
CLSG/GCEL Launch Webinar 1
The founding goals of CLSG are to advance the diagnosis and treatment of leukemia in Canada, by identifying diagnostic and management best practices, promoting Canada-wide standards-of-care, fostering clinical and basic leukemia research, and improving new drug access.
